Oxford Brain Diagnostics
Oxford Brain Diagnostics analyzes the cellular structure of the brain to support drug development and assist clinicians in addressing Alzheimer’s and other neurodegenerative conditions. Their technology assesses brain health based on changes in cellular structure, providing insights that enable the prediction, detection, quantification, tracking, and differentiation of neurodegenerative conditions.
- Cortical Disarray Measurement (CDM) technology
- MRI-based metrics for neurodegenerative conditions
- Support for drug development and personalised patient care